Icon

ZIMHI (nda212854)- (5MG/0.5ML (5MG/0.5ML))

NALOXONE HYDROCHLORIDE ZMI PHARMA
5MG/0.5ML (5MG/0.5ML)
No No
2041-Jun-14 Expired
None None
None No
ZIMHI is an opioid antagonist indicated in adult and pediatric patients for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. ZIMHI is intended for immediate administration as emergency therapy in settings where opioids may be present. ZIMHI is not a substitute for emergency medical care.
0 0 0
Total Other Developers 1
Drugs with Suitability No
5MG/0.5ML (5MG/0.5ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.